Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Datasea Inc DTSS Q2 2022 Earnings Substantial EPS Miss as Stock Rises on Uncertain Outlook HYPD Q1 2026 Earnings Significant EPS Miss Sends Stock Down Over 7 AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs SQNS Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction GRAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher